Target
Vasopressin V1a receptor
Ligand
BDBM316346
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
55±n/a nM
Citation
 Braje, WFroggett, JGeneste, HHornberger, WJantos, KKling, Avan Gaalen, M Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases US Patent  US9617226 Publication Date 4/11/2017 
Target
Name:
Vasopressin V1a receptor
Synonyms:
AVPR V1a | AVPR1 | AVPR1A | Antidiuretic hormone receptor 1a | V1AR_HUMAN | V1aR | VASOPRESSIN V1A | Vascular/hepatic-type arginine vasopressin receptor | Vasopressin V1 receptor | Vasopressin V1a receptor | Vasopressin receptor
Type:
Receptor
Mol. Mass.:
46820.18
Organism:
Homo sapiens (Human)
Description:
P37288
Residue:
418
Sequence:
MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST
  
Inhibitor
Name:
BDBM316346
Synonyms:
US9617226, Example 27 | cis-2-[2-(3-Chlorophenyl)-4-oxo-6-[3-(1-piperidylmethyl)cyclobutyl]quinazolin-3-yl]-N-cyclopropyl-acetamide
Type:
Small organic molecule
Emp. Form.:
C29H33ClN4O2
Mol. Mass.:
505.051
SMILES:
Clc1cccc(c1)-c1nc2ccc(cc2c(=O)n1CC(=O)NC1CC1)[C@@H]1C[C@H](CN2CCCCC2)C1 |r,wD:25.28,27.31,(-4,-.77,;-2.67,,;-2.67,1.54,;-1.33,2.31,;,1.54,;;-1.33,-.77,;1.33,-.77,;2.67,,;4,-.77,;5.33,,;6.67,-.77,;6.67,-2.31,;5.33,-3.08,;4,-2.31,;2.67,-3.08,;2.67,-4.62,;1.33,-2.31,;,-3.08,;,-4.62,;-1.33,-5.39,;1.33,-5.39,;1.33,-6.93,;2.1,-8.26,;.56,-8.26,;8,-3.08,;9.49,-2.68,;9.89,-4.17,;11.22,-4.94,;11.22,-6.48,;12.56,-7.25,;12.56,-8.79,;11.22,-9.56,;9.89,-8.79,;9.89,-7.25,;8.4,-4.57,)|
Structure:
Search PDB for entries with ligand similarity: